Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Giant cell tumor of temporomandibular joint masquerading as temporomandibular joint pain dysfunction syndrome: a rare case report

  • Received : 2016.07.08
  • Accepted : 2016.09.21
  • Published : 2017.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Giant cell tumor (GCT) of the craniofacial bones has been reported but they are not common. This tumor occurs more often in women than in men and predominantly affects patients around the third to fifth decade of life. GCTs are generally benign but can be locally aggressive as well. We report a case of GCT involving the temporomandibular joint (TMJ), which was initially thought to be temporomandibular disorder (TMD). A 22-year-old female presented with swelling and pain over the right temporal region for 18 months associated with jaw locking and clicking sounds. On examination, her jaw deviated to the right during opening and there was a $2{\times}2$ cm swelling over the right temporal region. Despite routine treatment for TMD, the swelling increased in size. Computed tomography and magnetic resonance imaging of the brain and TMJ revealed an erosive tumor of the temporal bone involving the TMJ which was displacing the temporal lobe. Surgical excision was done and the tumor removed completely. Histopathological examination was consistent with a GCT. No clinical or radiological recurrence was detected 10 months post-surgery.

Keywords

References

  1. Unni KK. Dahlin's bone tumors: general aspects and data on 11,087 cases. 5th ed. Philadelphia: Lippincott-Raven; 1996:263-85.
  2. Schajowicz F. Tumors and tumor-like lesions of bone: pathology, radiology, and treatment. 2nd ed. Berlin: Springer-Verlag; 1994:257-95.
  3. Bertoni F, Unni KK, Beabout JW, Ebersold MJ. Giant cell tumor of the skull. Cancer 1992;70:1124-32. https://doi.org/10.1002/1097-0142(19920901)70:5<1124::AID-CNCR2820700517>3.0.CO;2-P
  4. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol 2001;16:297-307.
  5. Huvos AG. Bone tumors: diagnosis, treatment and prognosis. Tumors of histiocytic or fibrohistiocytic origin. 2nd ed. Philadelphia: Saunders; 1991:429-67.
  6. Robbins SL, Cotran RS, Kumar V. Robbins pathological basis of disease. 5th ed. Philadelphia: WB Saunders; 1994:1245-6.
  7. Vanel D, Contesso G, Rebibo G, Zafrani B, Masselot J. Benign giant-cell tumours of bone with pulmonary metastases and favourable prognosis. Report on two cases and review of the literature. Skeletal Radiol 1983;10:221-6. https://doi.org/10.1007/BF00357894
  8. Leonard J, Gokden M, Kyriakos M, Derdeyn CP, Rich KM. Malignant giant-cell tumor of the parietal bone: case report and review of the literature. Neurosurgery 2001;48:424-9.
  9. Min BI, Park YW. A case of metastatic giant cell tumor arising in two-year old girl. J Korean Assoc Oral Maxillofac Surg 1988;14:82-7.
  10. Lee HJ, Lum C. Giant-cell tumor of the skull base. Neuroradiology 1999;41:305-7. https://doi.org/10.1007/s002340050753
  11. Morriss-Kay GM. Derivation of the mammalian skull vault. J Anat 2001;199:143-51. https://doi.org/10.1046/j.1469-7580.2001.19910143.x
  12. Findlay JM, Chiasson D, Hudson AR, Chui M. Giant-cell tumor of the middle cranial fossa. Case report. J Neurosurg 1987;66:924-8. https://doi.org/10.3171/jns.1987.66.6.0924
  13. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:453-62. https://doi.org/10.1016/j.tripleo.2011.04.021
  14. Lee BK. Evidence-based practice in the treatment of temporomandibular disorders. J Korean Assoc Oral Maxillofac Surg 2012;38:263. https://doi.org/10.5125/jkaoms.2012.38.5.263
  15. Wang CS, Lou JH, Liao JS, Ding XY, Du LJ, Lu Y, et al. Recurrence in giant cell tumour of bone: imaging features and risk factors. Radiol Med 2013;118:456-64. https://doi.org/10.1007/s11547-012-0860-4
  16. Purohit S, Pardiwala DN. Imaging of giant cell tumor of bone. Indian J Orthop 2007;41:91-6. https://doi.org/10.4103/0019-5413.32037
  17. Wysocki RW, Soni E, Virkus WW, Scarborough MT, Leurgans SE, Gitelis S. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome? Clin Orthop Relat Res 2015;473:706-15. https://doi.org/10.1007/s11999-014-4054-3
  18. Silvers AR, Som PM, Brandwein M, Chong JL, Shah D. The role of imaging in the diagnosis of giant cell tumor of the skull base. AJNR Am J Neuroradiol 1996;17:1392-5.
  19. Chen ZX, Gu DZ, Yu ZH, Qian TN, Huang YR, Hu YH, et al. Radiation therapy of giant cell tumor of bone: analysis of 35 patients. Int J Radiat Oncol Biol Phys 1986;12:329-34. https://doi.org/10.1016/0360-3016(86)90346-9
  20. Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 2012;18:4415-24. https://doi.org/10.1158/1078-0432.CCR-12-0578

Cited by

  1. Surgical Management of Giant Cell Tumor Involving the Lateral Skull Base : vol.30, pp.6, 2017, https://doi.org/10.1097/scs.0000000000005519
  2. Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review vol.131, pp.3, 2017, https://doi.org/10.3171/2018.4.jns1849